[ Visit Client Website ]

Before you can access ASH's online program, you must agree to the following:
  • Abstracts submitted to the ASH Annual Meeting are considered embargoed from the time of submission.
  • The media, companies and institutions issuing press releases, and others are required to abide by the embargo policies governing the Society’s annual meeting. Read ASH’s embargo policy for more information.
-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session .

54th ASH Annual Meeting and Exposition (December 8-11, 2012)

Thursday, December 6, 2012

3:00 PM-7:00 PM


Registration  
Events

Friday, December 7, 2012

7:00 AM-6:00 PM


Registration  
Events

9:00 AM-12:00 PM

12:00 PM-5:00 PM


Trainee Day  
Trainee Activities and Services

12:15 PM-1:15 PM

Trainee Day

12:30 PM-5:00 PM


Training Program Directors' Workshop  
Special-Interest Sessions

1:00 PM-7:00 PM


Workshop on Myeloid Development  
Special-Interest Sessions

1:15 PM-2:15 PM


Workshop on Myeloid Development - Signaling  
Special-Interest Sessions

1:30 PM-2:30 PM

Trainee Day

Trainee Day

Trainee Day

2:15 PM-3:00 PM

2:45 PM-3:45 PM

Trainee Day

Trainee Day

Trainee Day

Trainee Day

3:00 PM-3:15 PM

3:15 PM-4:15 PM

4:00 PM-5:00 PM

Trainee Day

4:45 PM-5:00 PM

5:00 PM-6:00 PM


Workshop on Myeloid Development - Stem Cells  
Special-Interest Sessions

5:00 PM-7:00 PM


Trainee Welcome Reception and Meeting  
Trainee Activities and Services

6:00 PM-7:00 PM

Saturday, December 8, 2012

7:00 AM-6:00 PM


Registration  
Events

7:30 AM-9:00 AM


Everyday Bleeding Disorders  
Education Program


Hematologic Diseases in Pregnancy  
Education Program


Immune Dysregulation  
Education Program

9:00 AM-9:30 AM

9:30 AM-11:00 AM


Secrets of Secretion  
Scientific Program


Stressed-Out Stem Cells  
Scientific Program

11:00 AM-12:30 PM

11:00 AM-5:00 PM


Exhibits Open  
Events

11:15 AM-12:15 PM


Clinical Relevance of Cytogenetics in Acute Lymphocytic Leukemia
Anthony V. Moorman, PhD Newcastle University, Newcastle-upon-Tyne United Kingdom

Grassroots Network Lunch  
Special-Interest Sessions


Hematologic Emergencies in Pregnancy and Delivery  
How I Treat: Bringing Science to Clinical Dilemmas


Hemophagocytic Lymphohistiocytosis  
How I Treat: Bringing Science to Clinical Dilemmas


Immune Tolerance Induction Therapy in Hemophiliacs with Inhibitors  
How I Treat: Bringing Science to Clinical Dilemmas


Implications of Clonal Evolution in Myelodysplastic Syndromes
Timothy Graubert Washington University in St. Louis, St. Louis, MO

L-Asparaginase-Associated Thrombosis  
How I Treat: Bringing Science to Clinical Dilemmas


Management of Unexplained Coagulopathies  
How I Treat: Bringing Science to Clinical Dilemmas


New Generation FLT3 Inhibitors in Acute Myeloid Leukemia
Mark J. Levis, MD, PhD Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD

Perioperative Management in Von Willebrand Disease  
How I Treat: Bringing Science to Clinical Dilemmas


Red Cell Storage  
How I Treat: Bringing Science to Clinical Dilemmas


Targeted Therapy for Lymphoma  
How I Treat: Bringing Science to Clinical Dilemmas


Trainee Career Development Lunch - Session I  
Trainee Activities and Services


Trainee Career Development Lunch - Session 2  
Trainee Activities and Services


Transfusion and When to Consider Granulocyte Transfusion  
How I Treat: Bringing Science to Clinical Dilemmas


Translation Research in Hemoglobinopathies
Elliott P. Vichinsky, MD Children's Hospital and Research Center Oakland, Oakland, CA

Tumor-Specific Vaccines
Jeffrey J. Molldrem, MD The University of Texas MD Anderson Cancer Center, Houston, TX

Turning Discovery Genomics into Clinical Genomics
Timothy J. Ley, MD Washington University in St. Louis, St. Louis, MO

What Do JAK2 Inhibitors Do in Myeloproliferative Neoplasms and How Do They Work?  
How I Treat: Bringing Science to Clinical Dilemmas

12:00 PM-1:30 PM


332. Antithrombotic Therapy I  
Oral and Poster Abstracts

12:30 PM-1:30 PM


Ham-Wasserman Lecture  
General Sessions

1:30 PM-2:00 PM

2:00 PM-3:30 PM


Everyday Bleeding Disorders  
Education Program


Hematologic Diseases in Pregnancy  
Education Program


Immune Dysregulation  
Education Program

3:30 PM-4:00 PM

4:00 PM-5:30 PM


3 P's In a Pod  
Education Program


How to Make a Red Blood Cell  
Scientific Program


Secrets of Secretion  
Scientific Program


Stressed-Out Stem Cells  
Scientific Program

5:30 PM-7:30 PM


102. Regulation of Iron Metabolism: Poster I  
Oral and Poster Abstracts


331. Pathophysiology of Thrombosis: Poster I  
Oral and Poster Abstracts


332. Antithrombotic Therapy: Poster I  
Oral and Poster Abstracts


633. Myelodysplastic Syndromes: Poster I  
Oral and Poster Abstracts


703. Adoptive Immunotherapy: Poster I  
Oral and Poster Abstracts


711. Cell Collection and Processing: Poster I  
Oral and Poster Abstracts


801. Gene Therapy and Transfer: Poster I  
Oral and Poster Abstracts

6:00 PM-7:30 PM


Practice Forum  
Special-Interest Sessions

6:30 PM-9:00 PM

7:30 PM-8:30 PM


Practice Forum Reception  
Special-Interest Sessions

Sunday, December 9, 2012

7:00 AM-9:00 AM


Hematology Course Directors’ Workshop  
Special-Interest Sessions

7:00 AM-5:00 PM


Registration  
Events

7:30 AM-9:00 AM

9:00 AM-9:30 AM

9:30 AM-11:00 AM


ASH/ASCO Joint Symposium  
Special-Interest Sessions


How to Make a Red Blood Cell  
Scientific Program

11:00 AM-1:30 PM

11:00 AM-4:30 PM


Exhibits Open  
Events

11:15 AM-12:15 PM


Acute Lymphocytic Leukemia in Older Adults  
How I Treat: Bringing Science to Clinical Dilemmas


Approach to Patients with Suboptimal Response to Initial Therapy  
How I Treat: Bringing Science to Clinical Dilemmas


Can We Separate Graft-Versus-Host Disease from Graft-Versus-Leukemia Effects?  
How I Treat: Bringing Science to Clinical Dilemmas


Chronic Lymphocytic Leukemia  
How I Treat: Bringing Science to Clinical Dilemmas


Clinical Guidelines on Testing For Heritable Thrombophilia  
How I Treat: Bringing Science to Clinical Dilemmas


Does Molecular Information in Acute Myeloid Leukemia Change Treatment Decisions?  
How I Treat: Bringing Science to Clinical Dilemmas


Does the Stem Cell Survive Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia and, If So, How?
Catriona Jamieson, MD, PhD University of California - San Diego, La Jolla, CA

Drug-Induced Immune Thrombocytopenia  
How I Treat: Bringing Science to Clinical Dilemmas


Hodgkin Lymphoma  
How I Treat: Bringing Science to Clinical Dilemmas


Immune Reconstitution After Allogeneic Transplantation
Krishna V. Komanduri, MD University of Miami Miller School of Medicine Sylvester Comprehensive Cancer Center, Miami, FL

Inherited Disorders of Bleeding and Clotting
David Ginsburg, MD Howard Hughes Medical Institute, Ann Arbor, MI

Management of Myelofibrosis  
How I Treat: Bringing Science to Clinical Dilemmas


Mantle Cell Lymphoma  
How I Treat: Bringing Science to Clinical Dilemmas


Myeloma  
How I Treat: Bringing Science to Clinical Dilemmas


Neutropenias  
How I Treat: Bringing Science to Clinical Dilemmas


Platelet Storage Disorders
Catherine P. M. Hayward, MD, PhD McMaster University, Hamilton, ON

Quality of Life and Other Health Outcome Measurements
Julie A. Panepinto, MD Medical College of Wisconsin, Children's Hospital of Wisconsin, Milwaukee, WI

Tailoring Thrombosis Management in The Elderly  
How I Treat: Bringing Science to Clinical Dilemmas


Translational and Clinical Gene Therapy
David A. Williams, MD Boston Children's Hospital, Harvard Medical School, Boston, MA

Transplant for Myelodysplastic Syndromes  
How I Treat: Bringing Science to Clinical Dilemmas

12:00 PM-1:30 PM

12:15 PM-1:15 PM


ASH/EHA Joint Symposium  
General Sessions

1:15 PM-1:45 PM


Announcement of Awards  
General Sessions

1:45 PM-2:00 PM

2:00 PM-4:00 PM


Plenary Scientific Session  
General Sessions


Plenary Scientific Session  
Oral and Poster Abstracts

4:00 PM-4:30 PM

4:30 PM-6:00 PM


603. Oncogenes and Tumor Suppressors I  
Oral and Poster Abstracts


632. Chronic Myeloid Leukemia - Therapy I  
Oral and Poster Abstracts


Virally Driven Lymphomas  
Spotlight Sessions

6:00 PM-8:00 PM


102. Regulation of Iron Metabolism: Poster II  
Oral and Poster Abstracts


331. Pathophysiology of Thrombosis: Poster II  
Oral and Poster Abstracts


332. Antithrombotic Therapy: Poster II  
Oral and Poster Abstracts


633. Myelodysplastic Syndromes: Poster II  
Oral and Poster Abstracts


703. Adoptive Immunotherapy: Poster II  
Oral and Poster Abstracts


801. Gene Therapy and Transfer: Poster II  
Oral and Poster Abstracts

6:15 PM-7:15 PM

6:30 PM-8:00 PM

Monday, December 10, 2012

7:00 AM-8:30 AM


711. Cell Collection and Processing I  
Oral and Poster Abstracts

7:00 AM-5:00 PM


Registration  
Events

7:30 AM-11:45 AM


Consultative Hematology Course  
Special-Interest Sessions

9:00 AM-10:00 AM


E. Donnall Thomas Lecture  
General Sessions

10:00 AM-10:30 AM

10:00 AM-2:00 PM


Exhibits Open  
Events

10:30 AM-12:00 PM

11:00 AM-1:30 PM

11:15 AM-12:15 PM

12:15 PM-1:15 PM

1:30 PM-2:30 PM


Ernest Beutler Lecture  
General Sessions

2:30 PM-2:45 PM

2:45 PM-4:15 PM


3 P's In a Pod  
Education Program


332. Antithrombotic Therapy II  
Oral and Poster Abstracts


703. Adoptive Immunotherapy I  
Oral and Poster Abstracts


711. Cell Collection and Processing II  
Oral and Poster Abstracts

4:30 PM-6:00 PM


801. Gene Therapy and Transfer I  
Oral and Poster Abstracts

6:00 PM-8:00 PM


332. Antithrombotic Therapy: Poster III  
Oral and Poster Abstracts


633. Myelodysplastic Syndromes: Poster III  
Oral and Poster Abstracts


703. Adoptive Immunotherapy: Poster III  
Oral and Poster Abstracts


801. Gene Therapy and Transfer: Poster III  
Oral and Poster Abstracts

6:15 PM-7:45 PM


603. Oncogenes and Tumor Suppressors III  
Oral and Poster Abstracts

Tuesday, December 11, 2012

7:00 AM-1:00 PM


Registration  
Events

7:15 AM-9:15 AM

7:30 AM-9:00 AM


603. Oncogenes and Tumor Suppressors II  
Oral and Poster Abstracts


632. Chronic Myeloid Leukemia - Therapy II  
Oral and Poster Abstracts


Late-Breaking Abstracts  
Late-breaking Abstracts


Late-Breaking Abstracts Session  
General Sessions

9:30 AM-9:45 AM

9:45 AM-11:15 AM


Presidential Symposium  
General Sessions

11:15 AM-11:30 AM


Business Meeting  
General Sessions

12:00 PM-1:00 PM


Best of ASH  
General Sessions